Pharmaceutical Approach
Nanoscale pertains to the size of one-billionth or 10−9 m of a material.
Nanoscience has revolutionized the pharmaceutical industry by enabling the production of improved therapeutic drugs with enhanced efficacy and lower toxicity. Nanoparticles can improve the pharmacokinetics of drugs by increasing their solubility, stability, and bioavailability.
Knowing the beneficial aspects of nanomedicine, AGCP is harnessing the applications of nanotechnology in treatment and prevention of diseases.
Targeted Delivery
Controlled delivery of drugs to specific sites — tumors, inflamed tissue, infected areas — reducing the amount of drug required and minimizing side effects.
Improved Solubility & Stability
Nanoparticles improve the solubility and stability of drugs, making them more effective in treating diseases.
Enhanced Bioavailability
Nanotechnology increases drug absorption and distribution in the body, allowing for lower doses with reduced toxicity.
AGCP's nanoemulsion platform — validated through Experiment 0001 achieving sub-10nm particle size with 4+ year stability